Navigation Links
International research team reports major findings in prevention and treatment of blood clots
Date:1/11/2011

toward better treatments as well as better ways to prevent blood clots," he said.

The second clinical trial, which included patients at the University of Oklahoma Health Sciences Center, found that the medication Rivaroxaban provided a simple, effective, single-drug approach for both short-term and continued long-term treatment of patients with deep vein thrombosis. Rivaroxaban is given orally in a fixed dose without the need for laboratory blood testing to monitor the anti-clotting effect. Current treatment methods, on the other hand, use two drugs, one given by injections under the skin once or twice a day for 5 to 10 days, followed by an oral medication that requires careful monitoring and dose adjustment based on results of regular blood tests.

"We are excited to have been able to participate in a study that is helping to advance the way we care for patients with deep vein thrombosis," said Suman Rathbun, M.D., a vascular medicine specialist at the OU Vascular Center. "Prevention is paramount, but we are not yet able to prevent 100 percent of these blood clots. So, it is important for us to continue to work toward new and improved treatments as well."

Scientists at OU and their colleagues worldwide are working diligently to find better and more practical tools to prevent and treat blood clots in the legs and lungs.

DVT affects at least 300,000 Americans each year. Most deep-vein blood clots occur in the lower leg or thigh. These blood clots can break off and travel through the bloodstream. When a clot travels to the lungs, the condition is called pulmonary embolism (PE), a serious condition that can cause damage to the lungs and death.

Researchers stress that while the results of the research released today are encouraging, the medications studied are not yet approved by the U.S. Food and Drug Administration.


'/>"/>

Contact: Diane Clay
diane-clay@ouhsc.edu
405-271-2323
University of Oklahoma
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. International consortium to examine the impact of medical devices on health and retirement
2. New international conference in bionic engineering
3. International clinical trial tests targeted drug for melanoma
4. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
5. Half of those travelling internationally not aware of potential health risks
6. From cholera to blindness, experts present cutting-edge research at international meeting
7. International summit held to stimulate collaborative clinical research on antiphospholipid syndrome
8. International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women
9. Boston, Oct. 21-24: Largest international pediatric oncology conference
10. International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health
11. International Robotic Urology Symposium+2011
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
International research team reports major findings in prevention and treatment of blood clots
(Date:11/27/2014)... Dr. Ronald Receveur, who has a leading Southern ... health tips before patients dig into the annual Thanksgiving feast. ... Albany affordable cosmetic dentistry, and his staff understand that ... While the staff wishes everyone a happy and safe holiday, ... can enjoy a feast that is also healthy on their ...
(Date:11/27/2014)... At The Little Gym, we know that being ... surprise when a recent study confirmed that regular physical ... Journal of Pediatrics found that “Promoting physical activity ... school years may be important not only for health, ... two groups of children; those that were engaging in ...
(Date:11/27/2014)... November 27, 2014 Ethane Web Technologies, an ... will provide a 10% Christmas discount on PPC service. The ... The discount offer will begin on 1 December 2014 and ... About this offer, a PPC professional working at Ethane Web ... for small businesses, as this big discount would make the ...
(Date:11/26/2014)... 2014 AlignLife, a chiropractic and ... kick-off of its annual Toy Drive. With the ... to donate to those in need throughout their ... to distribute the donations to those most in ... will be accepting donations at the clinics to ...
(Date:11/26/2014)... Sweetdressy.com, the well-known wedding dress manufacturer for the global ... dresses for ladies worldwide. Meanwhile, these graceful items are ... are very popular in the world and clients can ... , Sweetdressy.com believes that a company can attract ... and best services. The spirit of the company is ...
Breaking Medicine News(10 mins):Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 2Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 3Health News:New Albany Dental Practice Offers Oral Health Tips For Thanksgiving 4Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Cheap Prom Dresses For Ladies Introduced At SweetDressy.com 2
... New Dynamics of Ageing Programme (NDA), a collaboration between ... and Humanities Research Council, the Biotechnology and Biological Sciences ... the Economic and Social Research Council and the Medical ... applications to be funded under the programme. , ...
... Oct. 18 ReBuilder,Medical Technologies, Inc. (Pink ... by world-renowned medical device inventor David B.,Phillips, ... service organization and facilitation. (Logo: ... when many companies are outsourcing customer service ...
... Cost of Prescription Drugs, WASHINGTON, Oct. 18 ... following statement in response to,today,s House Judiciary Committee ... independent pharmacists sweeping antitrust,exemptions:, "This bill couldn,t ... and,consumers alike. As most everyone is searching for ...
... UK awarding body associated with hairdressing and beauty therapy ... a major UK Centre for Burns Research based at ... of its kind by The Vocational Training Charitable Trust ... pioneering research programme soon to start in South Wales. ...
... Children Under 5 in Madagascar to Sleep Under Bed ... More and,Sumitomo Chemical have teamed up to contribute to ... Madagascar between October 22-29. Led by the Malagasy ... six months to five years old receives a bed ...
... The Bayer Foundation,announced today it has awarded ... of Chemical & Biomolecular Engineering (UH CHBE) to,establish ... which is competitive with other prestigious fellowships,from the ... over a,three-year period to a graduate student pursuing ...
Cached Medicine News:Health News:Research for a better old age 2Health News:Research for a better old age 3Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 2Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 3Health News:£1 million donation for burns research in Wales 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 3Health News:Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston 2Health News:Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston 3
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in two upcoming investor conferences. On Tuesday, ... th Annual Piper Jaffray Healthcare Conference.  D. ... provide an update on the company beginning at 11:30 ...
(Date:11/26/2014)... , Nov. 26, 2014  Genomic Health, Inc. ... Popovits , Chairman, Chief Executive Officer and President, will ... Healthcare Conference at The New York Palace Hotel in ... 3 at 11:30 am Eastern Time (ET). ... the conference call, go to the  Investor Relations  section ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... findings of the first cost-effectiveness analysis of Vimpat® ... partial-onset seizures.  The findings were presented at the ... (ISPOR) annual meeting in Baltimore, MD, USA.   ... to analyze standard anti-epileptic drug therapy with and ...
... Pa., May 31, 2011 CSL Behring ... Designations (ODD) by the European Commission for the development of ... (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia ... to exclusively market recombinant factor VIIa fused with albumin in ...
Cached Medicine Technology:New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 2New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 3New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 4New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 5New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 6New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 7New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 8CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 2CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 3CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 4
... Improved Access in Open Procedures ... ,The ENDOPATH ETS Compact-Flex45 No-Knife Articulating ... a 45mm staple line for open ... either a standard blue cartridge, a ...
... The ETS45 and ETS-FLEX45 ... 45mm staple and cut line. ... the device suitable for many ... cutters are intended for transection, ...
... Auto Suture ENDO CLIP 5 mm ... The applier is designed for introduction ... Auto Suture trocar sleeve, or larger ... The overall length of the shaft ...
Insert only, Pilling-Weck medium clip size...
Medicine Products: